Top Markets
Coin of the day
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Rangering i aksjer #31257
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Aksjekurs
$0.39
Markedsverdi
$13.79M
Endring (1 dag)
-13.53%
Endring (1 år)
-68.80%
Land
IL
Handel NeuroSense Therapeutics Ltd. (NRSN)

Kategori

Historikk for aksjesplitt for NeuroSense Therapeutics Ltd. (NRSN)
Aksjen NeuroSense Therapeutics Ltd. (symbol: NRSN) har gjennomgått totalt 0 aksjesplitt.
Den nyeste splittelsen skjedde Aug 18, 2026.
Én NRSN-aksje kjøpt før Aug 18, 2026 tilsvarer i dag 0 NRSN-aksjer.
Liste over aksjesplitt
År Splitt Multiplikator Kumulativ multiplikator
Ikke nok data for de angitte datoene.
Aksjesplitt for lignende selskaper eller konkurrenter
Selskap Antall aksjesplitt Kumulativ multiplikator Land
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE